Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC
Clinical trial NCT04958811 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04958811
- Sponsor
- Georgetown University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2026-07-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.